This probably explains the acquisition and/or maintenance of metastatic, castration-resistant phenotype of the PCa cells, as an effective anticancer immune response requires T-cell activation and co-stimulation by the B7 ligand and CD28 receptor families on antigen-presenting cells (APC) and T cells, respectively [27]. The gene discussed is CD80; the disease is posterior cortical atrophy.